Home
Citadel Advisors reported a 2.8% stake in Allogene Therapeutics ALLO · 6,855,120 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 2.8%
- Last report
- 6.1% · filed 25/07/16
- Shares held
- 6,855,120 sh
- Class
- Common Stock, par value $0.001 per share (the "Shares")
- Holder
- Citadel Advisors
- Event date
- 26/03/31
- Filed
- 26/05/15
2.8% stake · below 5%
- Stake
- 2.8%
- Last report
- 6.1%
- Since last report
- −3.3pp
Allogene Therapeutics trades, last 26 weeks
What else happened in Allogene Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Citadel Advisors's other 5% stake reports
- Citadel Advisors
5% stakeVenu Holding
5% stakeVenu Holding
VENU
3.8% stake
2,365,505 sh
3.8% stake
Filed 08/14
- Citadel Advisors
5% stakeSpruce Biosciences
5% stakeSpruce Biosciences
SPRB
1.9% stake
51,919 sh
1.9% stake
Filed 08/14
- Citadel Advisors
5% stakeMomentus
5% stakeMomentus
MNTS
1.6% stake
309,865 sh
1.6% stake
Filed 08/14
- Citadel Advisors
5% stakeXCHG
5% stakeXCHG
XCH
9.7% stake
272,656,440 sh
9.7% stake
Filed 08/14
- Citadel Advisors
5% stakeVillage Farms International
5% stakeVillage Farms International
VFF
5.5% stake
6,689,240 sh
5.5% stake
Filed 08/14
